Cita APA (7a ed.)

Talebi, A., Dehairs, J., Rambow, F., Rogiers, A., Nittner, D., Derua, R., . . . Swinnen, J. V. (2018). Sustained SREBP-1-dependent lipogenesis as a key mediator of resistance to BRAF-targeted therapy. Nature Portfolio.

Cita Chicago Style (17a ed.)

Talebi, Ali, et al. Sustained SREBP-1-dependent Lipogenesis as a Key Mediator of Resistance to BRAF-targeted Therapy. Nature Portfolio, 2018.

Cita MLA (8a ed.)

Talebi, Ali, et al. Sustained SREBP-1-dependent Lipogenesis as a Key Mediator of Resistance to BRAF-targeted Therapy. Nature Portfolio, 2018.

Precaución: Estas citas no son 100% exactas.